FDA
Paliperidone Palmitate
The FDA lists this product in 16 strengths and forms.
Composition
- Active ingredients
- PALIPERIDONE PALMITATE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- PALIPERIDONE PALMITATE 39MG · InjectableANDA216674-005 · Tentative approval
- PALIPERIDONE PALMITATE 117MG · InjectableANDA216674-003 · Tentative approval
- PALIPERIDONE PALMITATE 78MG · InjectableANDA216674-004 · Tentative approval
- PALIPERIDONE PALMITATE 156MG · InjectableANDA216674-002 · Tentative approval
- PALIPERIDONE PALMITATE · SuspensionThis page
- PALIPERIDONE PALMITATE 1560MG/5.0ML · InjectionANDA215682-006 · Tentative approval
- PALIPERIDONE PALMITATE 819MG/2.625ML · InjectionANDA215682-004 · Tentative approval
- PALIPERIDONE PALMITATE 410MG/1.315ML · InjectionANDA215682-002 · Tentative approval
- PALIPERIDONE PALMITATE 1092MG/3.5ML · InjectionANDA215682-005 · Tentative approval
- PALIPERIDONE PALMITATE 546MG/1.75ML · InjectionANDA215682-003 · Tentative approval
- PALIPERIDONE PALMITATE 234MG/1.5ML · Suspension, extended release
At a glance
- Brand name
- Paliperidone Palmitate
- Route
- Extended release
- Dosage form
- Suspension
- Applicant
- Pharmascience Inc
- Status
- Tentative approval
- FDA approval
- 5 Feb 2024
- Application
- ANDA210397-001